Health Condition 1: E784- Other hyperlipidemia
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1,Patients willing to participate and follow the scheduled Visit plan, instruction, laboratory test present clinical trial with consent. 2.The patients, whom age between 18-70 years old. 3. Patients with previously diagnosed and confirmed known patient of Hyperlipoproteinemia. 4.Confirmed diagnosis of Hyperlipoproteinemia based on lipid profile tests (elevated total cholesterol range between 239 to 400 mgldl or LDL-C range between 159 to 400 mg/dl or triglycerides ranige between 199 to 700 mg/dl or low HDL-C from baseline value). 5. Patients having Peptic ulcers or any other bleeding disorders for Khadir Ghana capsule.
Exclusion criteria
Exclusion criteria: 1.The patient who used other anti-hyperlipidemic drugs four weeks before enrollment. 2. Patients of uncontrolled endocrine or metabolic disorder. 3. Patients who are taking oral steroids. 4. Patients having major illness malignancy, renal insutticiency etc. 5. Alcohol consumers and drug abusers. 6. Pregnant and lactating women. 7. Patients having Peptic ulcers or any other bleeding disorders for shigru Ghana capsule.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Reduction in lipid levels and improvement in lipid profiles. 2. Acacia catechu & Moringa oliferia are safe and well tolerated in patients with Hyperlipoproteinemia.Timepoint: 2 month | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Improve the quality of life and overall wellbeing in patients with Hyperlipoproteinemia. 2. I will identify potential adverse effects or interaction with other medications. 3. Reduction in LDC-C levelTimepoint: 30 days,60 days,90 days | — |
Countries
India
Contacts
MADAN MOHAN MALVIYA GOVERNMENT AYURVED COLLEGE